<DOC>
	<DOC>NCT01438827</DOC>
	<brief_summary>The purpose of the trial is to evaluate the efficacy of two dosing schedules of Avanz SQ+ (Standardised Quality) Phleum pratense compared to placebo in subjects with grass pollen induced allergic rhinoconjunctivitis with or without asthma.</brief_summary>
	<brief_title>Avanz Phleum Pratense Maintenance Dose</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<criteria>A history of grass pollen allergy Positive skin prick test to grass Positive Immunoglobulin E test to grass Other allergies overlapping the grass pollen season Severe Asthma (defined as a Forced expiratory volume in 1 second (FEV1) below 70 % after adequate treatment)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>